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A flow-through optosensing system for oxazepam recognition with fluorescence detection was performed by means of a molecular 
imprinted polymer based on its acid hydrolysis product, 2-amino-5-chlorobenzophenone. The synthesis was conducted via 
a noncovalent imprinting methodology, using methacrylic acid as a functional monomer and ethylene glycol dimethacrylate as 
a cross-linking agent. Hydrolysis (types and concentration of acids), polymer retention capacity, binding properties, and elution 
(selectivity and reversibility) conditions were optimized. The selected molecular imprinted polymer had a molar ratio composition 
of 1: 6:45 (template: functional monomer: cross-linker). The proposed method was applied to the determination of oxazepam in 
a pharmaceutical formulation. External standard calibration, standard additions calibration, and Youden’s calibration were 
carried out in order to evaluate constant and proportional errors due to the matrix. The developed metabolite-based recognition 
system for benzodiazepines is an innovative procedure that could be followed in routine and quality control assays.
1. Introduction
Oxazepam (OXA), 7-chloro-l,3-dihydro-3-hydroxy-5- 
phenyl-2H-l,4-benzodiazepin-2-one, is a therapeutically 
short-to-intermediate-acting benzodiazepine used to pro­
duce sedation, induce sleep, relieve anxiety, and muscle 
spasms [1]. Due to its sedative properties, it has a high 
potential for abuse specially when it is combined with other 
depressants such as alcohol or opiates [2]. Urine has been the 
most widely used biological matrix for the determination of 
benzodiazepines and metabolites in drug abuse testing and 
toxicology [3].
Several analytical methods have been proposed for OXA 
determination: most of them use chromatographic techniques 
and others use fluorometry and capillary electrophoresis; 
also, some electrochemical sensors have been developed 
[4-13]. Since benzodiazepine metabolites are converted to 
benzophenone, a sensitive determination method could 
be performed using the hydrolyzed product [5, 14].
Molecularly imprinted polymers (MIPs) are synthetic 
materials that act as artificial biomimetic receivers capable to 
recognize and specifically interact with the analyte used as 
a template in the polymerization process. The specificity and 
selectivity gained with MIPs make them suitable as recognition 
elements for chemical and biochemical sensors [15-28].
In this work, a rapid, simple, and low-cost analytical 
method is proposed for the indirect determination of OXA 
in pharmaceutical formulations based on the development 
of an optical sensor for its acid hydrolysis product, 2-amino- 
5-chlorobenzophenone (BZF). A MIP has been synthesized 
via the noncovalent imprinting methodology as a recogni­
tion element in a flow-through optosensing system with 
fluorescence detection.
2. Materials and Methods
2.1. Materials. Methacrylic acid (MAA) was purchased from 
Fluka (Buchs, Switzerland), and ethylene glycol dimethacrylate 
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(EGDMA) and a,a’-azoisobutyronitrile (AIBN) were acquired 
from Aldrich (Milwaukee, WI, USA). They were purified as 
described in a previous work [29].
All other chemicals were of analytical grade and used as 
received. Oxazepam (OXA) was kindly supplied by a phar­
maceutical store. 2-amino-5-chlorobenzophenone (BZF) 
(purity 98%) was acquired from Aldrich (Milwaukee, WI, 
USA). A pharmaceutical formulation (tablets) containing 
OXA was purchased from a local store. Double-distilled 
water was used.
Stock solutions of OXA and BZF were prepared in 
adequate solvents as needed for the planned assays.
2.2. Apparatus. All recordings of fluorescence spectra and 
fluorimetric measurements were carried out on a Perki- 
nElmer LS-50B luminescence spectrometer (Beaconsfield, 
England) equipped with a pulsed xenon lamp (half peak 
height <10^s, 60Hz), an R928 photomultiplier tube, and 
a computer working with FL Winlab software.
The optosensing manifold used for the luminescence 
measurements was similar to the one employed in a previous 
work [29]. A 25^L, 1.5mm path length, conventional flow- 
through quartz cell (Hellma, model 176.052-QS, Mullheim, 
Germany) was loaded with the synthesized MIP [29]. The as- 
packed active phase was used with satisfactory readings for 
several months. (All the experiments were carried out 
without changing the active phase from the flow cell.)
A four channel Gilson’s Minipuls 3 peristaltic pump 
(Villiers-le-Bel, France) fitted with organic solvent resistant 
Tygon tubing was used to generate the flowing streams. A 
Rheodyne 5020 rotatory valve (Rohnert Park, CA, USA) 
provided with a 500 u\. loop was employed for sample in­
troduction. PTFE tubes (0.8 mm internal diameter) were 
used throughout the flow system.
Gas chromatographic analysis (GC) were performed 
with a Shimadzu GC-2014 (Japan) provided with an AOC- 
20i automatic injector and FID detector working with 
a Restek RTx-65TG capillary column.
Absorption spectra were recorded on a Shimadzu UV-240 
(Japan) recording spectrophotometer, equipped with a 1.0 cm 
path length quartz cell. Derivative absorption spectra were 
performed applying simple mathematical calculations.
2.3. Oxazepam Hydrolysis. As temperature alone does not 
produce the OXA hydrolysis, aliquots of OXA working 
solutions were initially mixed with 0.1 M acid solutions 
(sulphuric, acetic, and hydrochloric acids) in screw-capped 
tubes and hydrolyzed at 100°C for 60 minutes to form BZF. 
After cooling, absorption spectra were registered and their 
first-order derivative spectra were obtained.
2.4. MIP/NIP Synthesis. A molecular imprinted polymer 
(MIP) with BZF was synthesized according to a standard 
method previously studied in our research group [29]. As BZF 
has an amino group, methacrylic acid (MAA) has been se­
lected as a functional monomer. In a screw-capped tube, 
a total of 21 mg of BZF (0.09 mmol), template, were dissolved
Figure 1: Oxazepam acid hydrolysis reaction.
in 2 mL of chloroform, porogen, by sonication for 15 minutes. 
Afterwards, 531 ¿/L (2.8 mmol) of EGDMA, a cross-linking 
agent, and 32 u\. (0.37 mmol) of MAA were added and shaken 
in a Vortex during another 15 minutes. With the tube im­
mersed in an ice bath, 3 mg (0.019 mmol) of AIBN, a radical 
initiator, was added and sonicated for 5 minutes. The mixture 
was degassed by bubbling N2 for 10 minutes. The tube was 
heated at 60°C for 16 hours. The polymer was removed from 
the tube, ground in an agatha mortar, and sieved to an average 
particle size of 70-100 mesh. The particles were washed in the 
Soxhlet extractor with acetic acid: methanol (10% v/v) until 
BZF could no longer be detected by UV absorption in the 
washing solution. Finally, the particles were washed with 
methanol and dried at 40°C during 24 hours. A nonimprinted 
polymer (NIP) was synthesized using the same procedure 
without the addition of BZF.
2.5. Binding Assays. Binding assays were performed contacting 
each MIP/NIP during 48 hours with BZF chloroformic stan­
dard solutions. After this time, the mixture was centrifuged and 
the supernatant was analyzed by gas chromatography (GC). A 
calibration graph with standard BZF solutions was prepared in 
order to quantify BZF concentration. The BZF concentration 
bonded to the polymer was calculated by subtracting the BZF 
concentration in the supernatant to the initial one.
2.6. Oxazepam Determination. The proposed method was 
applied to the determination of OXA in a pharmaceutical 
formulation (PausafrenT, 15 mg OXA, tablets). Five tablets were 
accurately weighed, powdered in an agatha mortar, and ho­
mogenized. An average mass of 1.150 g per tablet was calculated.
3. Results and Discussion
3.1. Oxazepam Hydrolysis. The acid hydrolysis of benzodi­
azepines to benzophenones has been previously reported 
[30,31]. The hydrolysis product of oxazepam (OXA), 2-amino- 
5-chlorobenzophenone (BZF), is shown in Figure 1.
As absorption spectra of OXA and its respective benzo­
phenone are overlapped, it is difficult to determine the BZF 
concentration in the presence of OXA when a partial hy­
drolysis takes place. The OXA and BZF first-order derivative 
spectra have two wavelengths at which dA/dX are zero: 
236.9 nm and 229.1 nm (Figure 2). These wavelengths are 
suitable for the quantification of both species after different 
hydrolysis treatments: BZF at 229.1 nm and OXA at 236.9 nm.
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----- OXA; 12 = 236.9 nm
-----BZF; 1 = 229.1 nm
Figure 2: OXA and BZF first-order absorption derivative spectra.
3 (nm)
-----OXA ....... OXA(H2SO40.1M)
----- OXA(HCIO.IM) ----- OXA (CHjCOOH 0.1 M)
Figure 3: OXA first-order absorption derivative spectra after 
partial hydrolysis. [OXA] = 3.50 x 10 5M.
Absorbances were measured at the mentioned wave­
lengths (Figure 3). From these values, it was deduced that the 
hydrolysis takes place with major efficiency in the presence 
of hydrochloric acid (HC1). Ihe tested concentration was 
inadequate to produce complete hydrolysis. Afterwards, the 
hydrolysis reaction was performed with a series of increasing 
HC1 molar concentration solutions. A 3 M HC1 concen­
tration was selected as the optimum one for the complete 
hydrolysis (Figure 4).
3.2. Binding Assays. In order to select the best retention 
capacity of the MIP, a series of polymers were synthesized 
maintaining a 7.5 EGDMA/MAA molar ratio (Table 1). The 
polymers were synthesized, ground, sieved, washed, and 
dried as previously stated. 2mL of a 2.52x10 4 M BZF
OXA
■■■ OXA(HCllM)
----- OXA (H Cl 3 M)
-----OXA(HC14.5M)
Figure 4: OXA first-order absorption derivative spectra after 
complete hydrolysis. [OXA] = 3.02 x 10 5 M.
Table 1: Polymers synthesized maintaining a 7.5 EGDMA/MAA 
molar ratio.
MIP [MAA]/[BZF]
BZF
(mmol)
MAA EGDMA
1 2 0.043 0.086 0.647
2 4 0.043 0.172 1.290
3 6 0.043 0.258 1.935
4 8 0.043 0.344 2.580
Figure 5: BZF peak area for each MIP/NIP after incubation time.
chloroformic solution was added to 13 mg of each MIP in 
a capped test tube. The tubes were shaken in a Vortex and let 
to stand for 48 hours at room temperature. After this time, 
the tubes were centrifuged at 4000 rpm for 5 minutes and the 
solutions were GO analyzed. Results are shown in Figure 5. 
All MIPs retain a greater BZF quantity than the NIPs. MIP 
#3 shows the best retention with an optimal MAA/BZF 
molar ratio equal to 6.
4 Journal of Analytical Methods in Chemistry
Table 2: Polymers synthesized maintaining a 6 MAA/BZF molar 
ratio.
MIP [EGDMA]/[MAA]
BZF
(mmol)
MAA EGDMA
1 2.5 0.043 0.258 0.645
2 5 0.043 0.258 1.290
3 7.5 0.043 0.258 1.935
4 10 0.043 0.258 2.580
Figure 6: BZF peak area for each MIP after incubation time.
In order to evaluate the optimum EGDMA/MAA molar 
ratio, a series of polymers were synthesized maintaining 
a 6 MAA/BZF molar ratio (Table 2). The polymers were 
synthesized, ground, sieved, washed, and dried. Binding 
assays were performed as abovementioned. Results are 
shown in Figure 6. MIP #3 presents the major retention 
capacity with a 7.5 EGDMA/MAA molar ratio.
3.3. MIP/NIP Optimized Synthesis: Optosensing System 
Evaluation. The working polymers (MIP and NIP) were syn­
thesized under the previously stated conditions (Section 3.2).
The MIP was introduced in the flow cell of the opto­
sensing system and was evaluated in a simple way with 
a methanol carrier solution containing 10% v/v acetic acid. 
The fluorescent signal was monitored setting the excitation 
and emission wavelengths at 220 nm and 336 nm, re­
spectively, with 10 nm of excitation and emission band­
widths. A carrier flow rate of 4mL/min was used, and 
a stable signal was obtained. When a 1.28 x 10 s M BZF 
methanolic solution was injected, a negative peak was ob­
tained returning to the baseline after a definite period of 
time. Certainly, the MIP recognizes and retains the BZF. The 
inverted peaks suggest that the interaction produces a quenching 
of the MIP fluorescence (Figure 7). No appreciable changes were 
detected when NIP was assayed (Figure 8).
Under the conditions previously established, solutions of 
different BZF concentrations were injected in the system. 
Figure 9 shows the diagram when different concentrations of 
BZF methanolic solutions were injected into the flow system 
using the synthesized MIP as the sensing material. The 
regeneration with the carrier solution is also shown.
Figure 7: MIP response profile for a 1.28 x 10 5 M BZF methanolic 
solution.
500
300 -
0 300 600 900
Time (s)
Figure 8: NIP response profile for a 1.28 x 10 5 M BZF methanolic 
solution.
Figure 9: MIP response profile for different BZF methanolic 
solution concentrations: 1.78x 10 5M, 3.40x10 5M, 4.98x10 5M, 
and 7.12 x 105 XI.
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Figure 10: Fluorescence response profile for BZF remov­
al/rebin ding in a MIP.
Figure 11: MIP response profile for BZF with different hex­
ane/isopropyl alcohol mixtures as a carrier: (a) 90:10 (v/v), (b) 70: 
30 (v/v), and (c) 30:70 (v/v).
Ihe polarity of the carrier solvent affects the BZF binding 
properties. A solvent with high polarity competes with the 
sample molecules for binding at the recognition sites. Ihe 
result is a weakness in the specific polar interaction leading 
BZF to go to the carrier solution. Otherwise, in nonpolar 
solvent, the molecule stays into the polymer. Thus, a non­
polar solvent should be used for detecting the quenching of 
the fluorescence caused by the BZF retention. A polar 
solvent should be then used for eluting the molecule from 
the polymer leaving the MIP in the unbound situation for 
receiving a new injection.
A first attempt was made with hexane as a nonpolar 
carrier solvent injecting a 3.40x10 5M BZF solution in 
hexane followed by an isopropyl alcohol injection. Experi­
mental working parameters were optimized; excitation and 
emission wavelengths were set at 410 and 515 nm, re­
spectively, with 10 nm and 5 nm corresponding bandwidths. 
This situation is shown in Figure 10. As can be seen, the 
change of solvents requires a too long time to restore the 
baseline leading to a nonsymmetrical peak and making the 
study unpractical. The next step was searching for a solvent 
that could let the BZF interact with the polymer (selectivity) 
and simultaneously be capable of reaching the initial con­
ditions without changing it (reversibility). As hexane and 
isopropyl alcohol are miscible, different proportions of both 
were assayed. A 3.40 x 10 5 M BZF solution in hexane was 
injected in 90:10, 70:30, and 30:70 (v/v) hexane/isopropyl 
alcohol mixtures. The obtained results showed that the peaks 
widths were diminished when the content of isopropyl al­
cohol was increased (Figure 11). On the other hand, the 
baseline was quickly restored, but the intensity was di­
minished. A 90:10 (v/v) ratio of hexane/isopropyl alcohol 
was selected for further studies. The carrier flow rate showed 
a similar behavior: an increase of its velocity produced 
a narrow peak width with low intensity on account of the 
lesser retention. A carrier flow rate of 5 mL/min was chosen.
3.4. Oxazepam Determination. Two kinds of calibration 
graphs were performed: (i) with BZF standards and (ii) with 
a solution of previously hydrolyzed OXA.
(i) Solutions of BZF were prepared in 3 M HC1. 3 mL of 
each one were extracted with the same volume of 
hexane.
(ii) Solutions prepared with the obtained product after 
OXA acid hydrolysis were treated in the same way 
as in (i).
The organic phases were separated and injected in the 
flow system, and the peak heights were measured. Cali­
bration graphs were obtained for the two cases and were 
analyzed using a t-test in order to compare both slopes [32]. 
It could be concluded that there is not any significant dif­
ference between the two calibration graphs. Therefore, 
calibration with BZF standards may be utilized for OXA 
quantification in a real sample (previous acid hydrolysis).
External standard and standard additions calibration 
graphs were carried out.
(i) External standard calibration graph: adequate aliquots 
of E24 x 10 3 M BZF stock solution were transferred to 
a series of 10.00 mL calibrated flasks attaining a final 
concentration range of 1.25 x 10 s M-7.50 x 10 5M 
after dilution with 3 M HC1.
(ii) Standard additions calibration graph: portions of 0.300 g 
of the sample were spiked with different amounts of 
OXA, diluted to 10.00 mL with 3M HC1, and hydro­
lyzed; one milliliter of the so-obtained solution was 
diluted to 10.00 mL with 3 M HC1 resulting in a mass 
range of 0-0.0125 g.
In both cases, extraction with hexane was performed and 
solutions were injected in the flow system. The slopes of both 
calibration graphs were compared by means of a t-test [32]. 
The results indicated the presence of an analyte/matrix 
interaction effect.
As matrix effects were found, the quantitative evaluation 
of the analyte was carried out by the standard additions and 
Youden calibration [33].
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Table 3: Results of the least-squares regression analysis.
Standard additions Youden’s calibration
n 10 8
Intercept 23.6 7.2
Slope 4165 g 49 g-1
Sa 0.9 0.7
Sb neg-1 U
$y/x 20.52 3.22
r 0.9969 0.9984
n: number of calibration data points; sa: standard deviation of the intercept; 
5b: standard deviation of the slope; sy/x: standard deviation of the regression; 
r: correlation coefficient.
SEN1
Y
LOD
LOQ
Dynamic range
Linear range
Table 4: Figures of merit.
0.42 m 1,-qg 
0.26mL-^g_1
11.2 qg-1111,
34.2 qg-iii I, 
11.2-123.3 qg-iiil. 
34.2-123.3 jt/g-mL-1
tSEN: calibration sensitivity; y: analytical sensitivity; LOD: limit of de- 
tection; LOQ: limit of quantification; LOD = 3.28 X50; LOQ=10xs0; 
s0 = (!/£>,) + (1/m) + (x2/^, (y- -x)2).
(i) Standard additions calibration graph was obtained 
by weighing five equal portions of the ground 
tablets, spiked with different amounts of OXA and 
individually used to prepare the solutions required 
for the flow injection system.
(ii) Youden’s calibration graph was obtained by weighing 
four different amounts of the ground tablets in the 
range of 0.25-0.85 g. Each of them was individually 
used to prepare the solutions required for the flow 
injection system.
The results of both calibration graphs are shown in Table 3.
Considering the mass of each tablet and the amount used 
to obtain the standard additions graph, the OXA content was 
calculated from the ratio of the difference between the or­
dinate intercepts of the standard additions and the Youden 
plots to the slope of the standard additions calibration graph. 
A value of 15.1 ±0.9 mg OXA per tablet was obtained, in 
agreement with the content provided by the manufacturer 
(15 mg OXA per tablet). Matrix effects may be possible due to 
the presence of /J-alanine in the sample. /J-alanine has an 
amino group that can interact with MAA and thus interfere 
with the BZF recognition. Taking into account that the 
product contains 500 mg of j3-alanine per tablet, the obtained 
result is certainly acceptable. The extraction with hexane may 
be another cause for the matrix effect. Table 4 summarizes the 
analytical figures of merit of the proposed methodology.
4. Conclusions
A novel optosensor for oxazepam has been developed based on 
its acid hydrolysis product, 2-amino-5-chlorobenzophenone. 
The novel use of the metabolite is beneficial in terms of the 
unnecessary handling of benzodiazepines. The proposed 
analytical methodology was applied for oxazepam de­
termination in a pharmaceutical formulation, avoiding matrix 
effects by means of the Youden calibration method. The de­
veloped fluorescence flow-through optosensing system has wider 
impacts on other domains in society other than academics as it is 
suitable for routine assays and quality control in pharmaceutical 
industries and drug abuse divisions as an alternative for 
chromatographic methodologies. It opens up possibilities for 
knowledge to be used in unexpected, creative, and innovative 
ways beyond normal professional research.
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